Clinical Trial Update: Photodynamic Therapy With Verteporfin for Corneal Neovascularization [NA]

View source ↗

Summary

A clinical trial evaluating photodynamic therapy with verteporfin for corneal neovascularization has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Neovascularization

Drugs mentioned

• Verteporfin (verteporfin)

Snippet

Sponsor: Chonnam National University Hospital | Conditions: Corneal Neovascularization | NA | Status: COMPLETED